首页 > 最新文献

Zhonghua wei zhong bing ji jiu yi xue最新文献

英文 中文
[An observational study on the clinical effects of in-line mechanical in-exsufflation in mechanical ventilated patients]. [机械通气患者在线机械通气的临床效果观察研究]。
Q3 Medicine Pub Date : 2025-03-01 DOI: 10.3760/cma.j.cn121430-20241008-00821
Bilin Wei, Huifang Zhang, Xiang Si, Wenxuan Yu, Xiangru Chen, Hao Yuan, Fei Pei, Xiangdong Guan
<p><strong>Objective: </strong>To evaluate the safety and clinical therapeutic effect of in-line mechanical in-exsufflation to assist sputum clearance in patients with invasive mechanical ventilation.</p><p><strong>Methods: </strong>A prospective observational study was conducted at the department of critical care medicine, the First Affiliated Hospital of Sun Yat-sen University from April 2022 to May 2023. Patients who were invasively ventilated and treated with in-line mechanical in-exsufflation to assist sputum clearance were enrolled. Baseline data were collected. Sputum viscosity, oxygenation index, parameters of ventilatory function and respiratory mechanics, clinical pulmonary infection score (CPIS) and vital signs before and after day 1, 2, 3, 5, 7 of use of the in-line mechanical in-exsufflation were assessed and recorded. Statistical analyses were performed by using generalized estimating equation (GEE).</p><p><strong>Results: </strong>A total of 13 invasively ventilated patients using in-line mechanical in-exsufflation were included, all of whom were male and had respiratory failure, with the main cause being cervical spinal cord injury/high-level paraplegia (38.46%). Before the use of the in-line mechanical in-exsufflation, the proportion of patients with sputum viscosity of grade III was 38.46% (5/13) and decreased to 22.22% (2/9) 7 days after treatment with in-line mechanical in-exsufflation. With the prolonged use of the in-line mechanical in-exsufflation, the patients' CPIS scores tended to decrease significantly, with a mean decrease of 0.5 points per day (P < 0.01). Oxygenation improved significantly, with the oxygenation index (PaO<sub>2</sub>/FiO<sub>2</sub>) increasing by a mean of 23.3 mmHg (1 mmHg ≈ 0.133 kPa) per day and the arterial partial pressure of oxygen increasing by a mean of 12.6 mmHg per day (both P < 0.01). Compared to baseline, the respiratory mechanics of the patients improved significantly 7 days after in-line mechanical in-exsufflation use, with a significant increase in the compliance of respiratory system (Cst) [mL/cmH<sub>2</sub>O (1 cmH<sub>2</sub>O ≈ 0.098 kPa): 55.6 (50.0, 58.0) vs. 40.9 (37.5, 50.0), P < 0.01], and both the airway resistance and driving pressure (DP) were significantly decreased [airway resistance (cmH<sub>2</sub>O×L<sup>-1</sup>×s<sup>-1</sup>): 9.6 (6.9, 10.5) vs. 12.0 (10.0, 13.0), DP (cmH<sub>2</sub>O): 9.0 (9.0, 12.0) vs. 11.0 (10.0, 15.0), both P < 0.01]. At the same time, no new lung collapse was observed during the treatment period. No significant discomfort was reported by patients, and there were no substantial changes in heart rate, systolic blood pressure, diastolic blood pressure, and mean arterial pressure before and after the in-line mechanical in-exsufflation treatment.</p><p><strong>Conclusions: </strong>The combined use of the in-line mechanical in-exsufflation to assist sputum clearance in patients on invasive mechanical ventilation can effectively improve sputum ch
目的:评价有创机械通气患者在线机械呼气辅助清痰的安全性及临床疗效。方法:于2022年4月至2023年5月在中山大学第一附属医院重症医学科进行前瞻性观察研究。接受有创通气和在线机械呼气辅助清痰治疗的患者被纳入研究。收集基线数据。评估并记录患者使用在线机械通气前后第1、2、3、5、7天的痰粘度、氧合指数、通气功能及呼吸力学参数、临床肺部感染评分(CPIS)及生命体征。采用广义估计方程(GEE)进行统计分析。结果:共纳入13例有创通气患者,均为男性,均存在呼吸衰竭,主要原因为颈脊髓损伤/高位截瘫(38.46%)。在使用在线机械充气前,患者痰黏度为III级的比例为38.46%(5/13),在使用在线机械充气治疗7天后降至22.22%(2/9)。随着使用时间的延长,患者的CPIS评分有明显下降的趋势,平均每天下降0.5分(P < 0.01)。氧合性明显改善,氧合指数(PaO2/FiO2)平均每天升高23.3 mmHg (1 mmHg≈0.133 kPa),动脉血氧分压平均每天升高12.6 mmHg (P均< 0.01)。与基线相比,患者在连续使用机械呼气后7 d呼吸力学明显改善,呼吸系统顺应性(Cst)明显增加[mL/cmH2O (1 cmH2O≈0.098 kPa): 55.6 (50.0, 58.0) vs. 40.9 (37.5, 50.0), P < 0.01],气道阻力和驱动压力(DP)均显著降低[气道阻力(cmH2O×L-1×s-1): 9.6 (6.9, 10.5) vs. 12.0 (10.0, 13.0), DP (cmH2O):9.0(9.0, 12.0)和11.0 (10.0,15.0),P < 0.01)。同时,治疗期间未见新发肺萎陷。患者未报告明显不适,在进行在线机械通气治疗前后,心率、收缩压、舒张压和平均动脉压均无明显变化。结论:有创机械通气患者联合应用在线机械呼气辅助清痰可有效改善痰液特征、氧合及呼吸力学。患者对在线机械通气耐受良好,无治疗相关不良事件,证明了其有效性和安全性。
{"title":"[An observational study on the clinical effects of in-line mechanical in-exsufflation in mechanical ventilated patients].","authors":"Bilin Wei, Huifang Zhang, Xiang Si, Wenxuan Yu, Xiangru Chen, Hao Yuan, Fei Pei, Xiangdong Guan","doi":"10.3760/cma.j.cn121430-20241008-00821","DOIUrl":"https://doi.org/10.3760/cma.j.cn121430-20241008-00821","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To evaluate the safety and clinical therapeutic effect of in-line mechanical in-exsufflation to assist sputum clearance in patients with invasive mechanical ventilation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A prospective observational study was conducted at the department of critical care medicine, the First Affiliated Hospital of Sun Yat-sen University from April 2022 to May 2023. Patients who were invasively ventilated and treated with in-line mechanical in-exsufflation to assist sputum clearance were enrolled. Baseline data were collected. Sputum viscosity, oxygenation index, parameters of ventilatory function and respiratory mechanics, clinical pulmonary infection score (CPIS) and vital signs before and after day 1, 2, 3, 5, 7 of use of the in-line mechanical in-exsufflation were assessed and recorded. Statistical analyses were performed by using generalized estimating equation (GEE).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 13 invasively ventilated patients using in-line mechanical in-exsufflation were included, all of whom were male and had respiratory failure, with the main cause being cervical spinal cord injury/high-level paraplegia (38.46%). Before the use of the in-line mechanical in-exsufflation, the proportion of patients with sputum viscosity of grade III was 38.46% (5/13) and decreased to 22.22% (2/9) 7 days after treatment with in-line mechanical in-exsufflation. With the prolonged use of the in-line mechanical in-exsufflation, the patients' CPIS scores tended to decrease significantly, with a mean decrease of 0.5 points per day (P &lt; 0.01). Oxygenation improved significantly, with the oxygenation index (PaO&lt;sub&gt;2&lt;/sub&gt;/FiO&lt;sub&gt;2&lt;/sub&gt;) increasing by a mean of 23.3 mmHg (1 mmHg ≈ 0.133 kPa) per day and the arterial partial pressure of oxygen increasing by a mean of 12.6 mmHg per day (both P &lt; 0.01). Compared to baseline, the respiratory mechanics of the patients improved significantly 7 days after in-line mechanical in-exsufflation use, with a significant increase in the compliance of respiratory system (Cst) [mL/cmH&lt;sub&gt;2&lt;/sub&gt;O (1 cmH&lt;sub&gt;2&lt;/sub&gt;O ≈ 0.098 kPa): 55.6 (50.0, 58.0) vs. 40.9 (37.5, 50.0), P &lt; 0.01], and both the airway resistance and driving pressure (DP) were significantly decreased [airway resistance (cmH&lt;sub&gt;2&lt;/sub&gt;O×L&lt;sup&gt;-1&lt;/sup&gt;×s&lt;sup&gt;-1&lt;/sup&gt;): 9.6 (6.9, 10.5) vs. 12.0 (10.0, 13.0), DP (cmH&lt;sub&gt;2&lt;/sub&gt;O): 9.0 (9.0, 12.0) vs. 11.0 (10.0, 15.0), both P &lt; 0.01]. At the same time, no new lung collapse was observed during the treatment period. No significant discomfort was reported by patients, and there were no substantial changes in heart rate, systolic blood pressure, diastolic blood pressure, and mean arterial pressure before and after the in-line mechanical in-exsufflation treatment.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;The combined use of the in-line mechanical in-exsufflation to assist sputum clearance in patients on invasive mechanical ventilation can effectively improve sputum ch","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 3","pages":"262-267"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143812479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Practice guideline on the prevention and treatment of central line associated bloodstream infection in 2025]. [2025年预防和治疗中央静脉相关血流感染实践指南]。
Q3 Medicine Pub Date : 2025-03-01 DOI: 10.3760/cma.j.cn121430-20250301-00199
Medicine Chinese Society Of Critical Care

Central line associated bloodstream infection (CLABSI) is the most severe complication of indwelling intravascular catheters and one of the most common causes of intensive care unit (ICU)- or hospital-acquired infections. Once CLABSI occurs, it significantly increases the risk of mortality, long of hospital stay, and healthcare economic burden. In recent years, multiple large-scale clinical studies on the diagnosis, treatment, and prevention of CLABSI have been completed, providing evidence-based medical support for related practices. Additionally, evolving global trends in antibiotic resistance epidemiology and the development of novel antimicrobial agents necessitate adjustments in clinical management strategies. Based on these developments, the Chinese Society of Critical Care Medicine has updated and revised the Guideline on the Prevention and Treatment of Intravascular Catheter-Related Infections (2007). This guideline was developed following the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system for evidence quality assessment. Guided by clinical questions, the working group initiated the process by defining key clinical issues, conducting literature searches, screening studies, performing meta-analyses, and synthesizing evidence-based findings to draft preliminary recommendations. These recommendations underwent iterative revisions through expert panel reviews, remote and in-person meetings, and two rounds of voting by the Standing Committee of the Chinese Society of Critical Care Medicine before finalization. The guideline comprises 52 recommendations, focusing on adult patients with central venous catheters in ICU. Key areas addressed include: selection of catheter insertion sites and techniques, catheter type and design, catheter management, prevention, diagnosis, and treatment of CLABSI. The guideline aims to provide ICU healthcare professionals with best practices for central line management, ensuring standardized clinical protocols for adult CLABSI.

中心静脉相关血流感染(CLABSI)是留置血管内导管最严重的并发症,也是重症监护病房(ICU)或医院获得性感染的最常见原因之一。一旦发生CLABSI,它会显著增加死亡风险、住院时间延长和医疗经济负担。近年来,在CLABSI的诊断、治疗和预防方面完成了多项大规模临床研究,为相关实践提供了循证医学支持。此外,抗生素耐药性流行病学的全球趋势和新型抗菌药物的发展需要调整临床管理策略。基于这些进展,中国重症医学学会更新和修订了《血管内导管相关感染的预防和治疗指南》(2007年)。本指南是根据证据质量评估的建议分级、评估、发展和评价(GRADE)系统制定的。在临床问题的指导下,工作组通过定义关键临床问题、进行文献检索、筛选研究、进行荟萃分析和综合循证结果来起草初步建议,从而启动了这一过程。这些建议经过专家小组评审、远程和面对面会议、中国危重医学学会常务委员会两轮投票等反复修订后定稿。该指南包括52条建议,重点是ICU中心静脉置管的成人患者。讨论的关键领域包括:导管插入部位和技术的选择,导管类型和设计,导管管理,预防,诊断和治疗CLABSI。该指南旨在为ICU医疗保健专业人员提供中央线管理的最佳实践,确保成人CLABSI的标准化临床协议。
{"title":"[Practice guideline on the prevention and treatment of central line associated bloodstream infection in 2025].","authors":"Medicine Chinese Society Of Critical Care","doi":"10.3760/cma.j.cn121430-20250301-00199","DOIUrl":"https://doi.org/10.3760/cma.j.cn121430-20250301-00199","url":null,"abstract":"<p><p>Central line associated bloodstream infection (CLABSI) is the most severe complication of indwelling intravascular catheters and one of the most common causes of intensive care unit (ICU)- or hospital-acquired infections. Once CLABSI occurs, it significantly increases the risk of mortality, long of hospital stay, and healthcare economic burden. In recent years, multiple large-scale clinical studies on the diagnosis, treatment, and prevention of CLABSI have been completed, providing evidence-based medical support for related practices. Additionally, evolving global trends in antibiotic resistance epidemiology and the development of novel antimicrobial agents necessitate adjustments in clinical management strategies. Based on these developments, the Chinese Society of Critical Care Medicine has updated and revised the Guideline on the Prevention and Treatment of Intravascular Catheter-Related Infections (2007). This guideline was developed following the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system for evidence quality assessment. Guided by clinical questions, the working group initiated the process by defining key clinical issues, conducting literature searches, screening studies, performing meta-analyses, and synthesizing evidence-based findings to draft preliminary recommendations. These recommendations underwent iterative revisions through expert panel reviews, remote and in-person meetings, and two rounds of voting by the Standing Committee of the Chinese Society of Critical Care Medicine before finalization. The guideline comprises 52 recommendations, focusing on adult patients with central venous catheters in ICU. Key areas addressed include: selection of catheter insertion sites and techniques, catheter type and design, catheter management, prevention, diagnosis, and treatment of CLABSI. The guideline aims to provide ICU healthcare professionals with best practices for central line management, ensuring standardized clinical protocols for adult CLABSI.</p>","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 3","pages":"193-220"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143812597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Design and application of a height measuring instrument for ventricular drainage catheter]. 一种心室引流管高度测量仪的设计与应用
Q3 Medicine Pub Date : 2025-03-01 DOI: 10.3760/cma.j.cn121430-20240812-00692
Qingchen Zhai, Guanjie Chen, Jianwei Li, Junping Li, Lu Ma

Ventriculostomy drainage is one of the commonly used surgical techniques in neurocritical care, which can relieve intracranial hypertension and facilitate postoperative cerebrospinal fluid and intracranial pressure monitoring. By placing a drainage tube in the ventricle, blood and fluid accumulation within the ventricle are drained out of the brain, reducing intracranial pressure and preventing brain tissue damage. Clinically, the speed of ventriculostomy drainage is often controlled by measuring the height difference between the drainage opening and the plane of the ventricle, ensuring the safe and effective reduction of intracranial pressure, facilitating the implementation of clinical management plans, and preventing complications. However, how to easily, safely, and effectively measure the height difference between the drainage opening and the ventricular plane remains a challenge in nursing management. Currently, clinical practice often uses a tape measure to measure the height of the ventriculostomy drainage, a process that is cumbersome and time-consuming and susceptible to human error, leading to inaccurate measurements. However, the challenge of easily, safely, and effectively detecting the height difference between the drainage opening and the ventricular plane remains a difficult problem in nursing management. To address this issue, the medical and nursing staff of the intensive care unit (ICU) at Zhongda Hospital, Southeast University, jointly designed a novel ventriculostomy drainage height measurement device, which has been granted a national utility model patent (patent number: ZL 2022 2 1400920.9). This device can be easily and securely fixed to an infusion stand. Using a level within the horizontal measuring part and a rotational structure, the vertical measuring part of the device is adjusted to be perpendicular to the ground. After opening the limit clip, the horizontal part is manually guided down to the appropriate height. The front end of the horizontal measuring part is then extended towards the patient's head, and after confirming the position, the limit clip is closed. At this point, the horizontal height difference between the drainage opening and the ventricular plane can be accurately measured. When temporarily finishing the height measurement of the drainage tube, the device can be folded and stored by retracting the horizontal measuring part and rotating components. This measuring device has a simple operation process, which can improve the accuracy and reliability of the drainage height measurement, enhance treatment outcomes and patient safety, reduce the workload of nursing staff, and has certain clinical promotion and practical value.

脑室造口引流术是神经重症监护常用的外科技术之一,可缓解颅内高压,便于术后脑脊液和颅内压监测。通过在脑室置入引流管,将脑室内的血液和积液排出脑外,降低颅内压,防止脑组织损伤。临床上,通常通过测量引流口与脑室平面的高度差来控制脑室造口引流的速度,确保安全有效地降低颅内压,便于临床管理方案的实施,预防并发症的发生。然而,如何方便、安全、有效地测量引流口与脑室平面之间的高度差仍是护理管理中的一个难题。目前,临床实践中通常使用卷尺测量脑室造口引流管的高度,这一过程繁琐耗时,且容易出现人为误差,导致测量结果不准确。然而,如何轻松、安全、有效地检测引流口与脑室平面之间的高度差仍是护理管理中的难题。针对这一问题,东南大学附属中大医院重症监护室(ICU)的医护人员共同设计了一种新型脑室造口引流高度测量装置,并获得了国家实用新型专利(专利号:ZL 2022 2 1400920.9)。该装置可方便、牢固地固定在输液架上。利用水平测量部分内的水平仪和旋转结构,可将该装置的垂直测量部分调整到与地面垂直。打开限位夹后,手动将水平测量部分向下引导至适当高度。然后将水平测量部分的前端伸向患者头部,确认位置后关闭限位夹。此时,可准确测量引流口与心室平面之间的水平高度差。当暂时完成引流管的高度测量时,可将水平测量部分和旋转部件收回,将设备折叠存放。该测量装置操作过程简单,可提高引流高度测量的准确性和可靠性,提高治疗效果和患者安全性,减轻护理人员的工作量,具有一定的临床推广和实用价值。
{"title":"[Design and application of a height measuring instrument for ventricular drainage catheter].","authors":"Qingchen Zhai, Guanjie Chen, Jianwei Li, Junping Li, Lu Ma","doi":"10.3760/cma.j.cn121430-20240812-00692","DOIUrl":"https://doi.org/10.3760/cma.j.cn121430-20240812-00692","url":null,"abstract":"<p><p>Ventriculostomy drainage is one of the commonly used surgical techniques in neurocritical care, which can relieve intracranial hypertension and facilitate postoperative cerebrospinal fluid and intracranial pressure monitoring. By placing a drainage tube in the ventricle, blood and fluid accumulation within the ventricle are drained out of the brain, reducing intracranial pressure and preventing brain tissue damage. Clinically, the speed of ventriculostomy drainage is often controlled by measuring the height difference between the drainage opening and the plane of the ventricle, ensuring the safe and effective reduction of intracranial pressure, facilitating the implementation of clinical management plans, and preventing complications. However, how to easily, safely, and effectively measure the height difference between the drainage opening and the ventricular plane remains a challenge in nursing management. Currently, clinical practice often uses a tape measure to measure the height of the ventriculostomy drainage, a process that is cumbersome and time-consuming and susceptible to human error, leading to inaccurate measurements. However, the challenge of easily, safely, and effectively detecting the height difference between the drainage opening and the ventricular plane remains a difficult problem in nursing management. To address this issue, the medical and nursing staff of the intensive care unit (ICU) at Zhongda Hospital, Southeast University, jointly designed a novel ventriculostomy drainage height measurement device, which has been granted a national utility model patent (patent number: ZL 2022 2 1400920.9). This device can be easily and securely fixed to an infusion stand. Using a level within the horizontal measuring part and a rotational structure, the vertical measuring part of the device is adjusted to be perpendicular to the ground. After opening the limit clip, the horizontal part is manually guided down to the appropriate height. The front end of the horizontal measuring part is then extended towards the patient's head, and after confirming the position, the limit clip is closed. At this point, the horizontal height difference between the drainage opening and the ventricular plane can be accurately measured. When temporarily finishing the height measurement of the drainage tube, the device can be folded and stored by retracting the horizontal measuring part and rotating components. This measuring device has a simple operation process, which can improve the accuracy and reliability of the drainage height measurement, enhance treatment outcomes and patient safety, reduce the workload of nursing staff, and has certain clinical promotion and practical value.</p>","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 3","pages":"294-296"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143812547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Association between albumin treatment and the prognosis of acute kidney injury patients: a retrospective study based on the MIMIC-IV database]. [白蛋白治疗与急性肾损伤患者预后的关系:基于 MIMIC-IV 数据库的回顾性研究]。
Q3 Medicine Pub Date : 2025-03-01 DOI: 10.3760/cma.j.cn121430-20230901-00723
Xinyuan Zhang, Yan Zhuang, Linfeng Dai, Haidong Zhang, Qiuhua Chen, Qingfang Nie
<p><strong>Objective: </strong>To assess the impact of albumin (Alb) administration on the prognosis of patients with acute kidney injury (AKI).</p><p><strong>Methods: </strong>Clinical data of AKI patients in the intensive care unit (ICU) were retrospectively analyzed from the American Medical Information Mart of Intensive Care-IV (MIMIC-IV), including demographic data, acute physiology score (APS), comorbidities, vital signs, laboratory indicators, treatment status, ICU length of stay, and outcome indicators. The main outcome measure is ICU mortality. AKI patients were divided into Alb infusion group and Alb non infusion group based on whether they received Alb treatment. Multiple imputation was used to process missing data and eliminate variables that missing more than 30%. To ensure the stability of the results, propensity score matching (PSM) and inverse probability weighting (IPW) were used to correct the results. Using Kaplan-Meier survival curve and Cox proportional hazards regression model to evaluate the effect of Alb infusion on ICU survival rate in AKI patients. Perform subgroup analysis based on patient age, gender, and comorbidities to evaluate the prognostic effects of Alb on different patient subgroups.</p><p><strong>Results: </strong>A total of 6 390 AKI patients were included, including 1 721 in the Alb infusion group and 4 669 in the Alb non infusion group. After adjusting for key covariates in the Cox regression model, compared with the Alb non infusion group, patients in the Alb infusion group were significantly younger in age, with APS III score, proportion of vasoactive drugs and continuous renal replacement therapy (CRRT) use, sepsis proportion, heart rate, respiratory frequency, aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatinine (Cr), lactic acid (Lac), and arterial partial pressure of carbon dioxide (PaCO<sub>2</sub>) levels significantly higher. The proportion of hypertension, myocardial infarction, and congestive heart failure, as well as blood pressure, urine output, platelet count (PLT), and Alb levels were significantly lower. The results of univariate and multivariate Cox regression analysis on the raw data showed that the risk of death in the Alb infusion group was significantly lower than that in the Alb non infusion group [hazard ratio (HR) = 0.69, 95% confidence interval (95%CI) was 0.60-0.80, all P < 0.05]. The results after propensity score matching (PSM) and inverse probability weighting (IPW) processing are consistent with the original data trend (both P < 0.05). The Kaplan-Meier survival curve showed that the cumulative survival rate during ICU stay in the Alb infusion group was significantly higher than that in the Alb non infusion group (24.48% vs. 12.17%, Log-Rank test: χ<sup>2</sup> = 74.26, P < 0.05). Subgroup analysis shows that Alb infusion has a more significant survival benefit for AKI patients who use vasoactive drugs, have concurrent sepsis, and do not have liver diseas
目的:探讨白蛋白(Alb)给药对急性肾损伤(AKI)患者预后的影响。方法:回顾性分析美国重症监护医学信息市场(MIMIC-IV)重症监护病房(ICU) AKI患者的临床资料,包括人口统计学资料、急性生理评分(APS)、合并症、生命体征、实验室指标、治疗情况、ICU住院时间和结局指标。主要结局指标为ICU死亡率。AKI患者根据是否接受Alb治疗分为输注Alb组和未输注Alb组。采用多重插值对缺失数据进行处理,剔除缺失量大于30%的变量。为了保证结果的稳定性,采用倾向得分匹配(PSM)和逆概率加权(IPW)对结果进行校正。采用Kaplan-Meier生存曲线和Cox比例风险回归模型评价白蛋白输注对AKI患者ICU生存率的影响。根据患者的年龄、性别和合并症进行亚组分析,评估白蛋白对不同亚组患者的预后影响。结果:共纳入AKI患者6 390例,其中输注Alb组1 721例,未输注Alb组4 669例。在Cox回归模型中对关键协变量进行调整后,与非输注Alb组相比,输注Alb组患者年龄明显年轻化,APS III评分、血管活性药物及持续肾替代治疗(CRRT)使用比例、败血症比例、心率、呼吸频率、天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)、肌酐(Cr)、乳酸(Lac)、动脉二氧化碳分压(PaCO2)水平明显升高。高血压、心肌梗死、充血性心力衰竭的比例以及血压、尿量、血小板计数(PLT)、Alb水平均显著降低。原始资料单因素和多因素Cox回归分析结果显示,输注白蛋白组的死亡风险显著低于未输注白蛋白组[危险比(HR) = 0.69, 95%可信区间(95% ci)为0.60 ~ 0.80,P均< 0.05]。经倾向得分匹配(PSM)和逆概率加权(IPW)处理后的结果与原始数据趋势一致(P < 0.05)。Kaplan-Meier生存曲线显示,输注白蛋白组患者在ICU期间的累积生存率显著高于未输注白蛋白组(24.48% vs 12.17%), Log-Rank检验:χ2 = 74.26, P < 0.05)。亚组分析显示,对于使用血管活性药物、并发脓毒症且无肝脏疾病的AKI患者,输注白蛋白具有更显著的生存获益。结论:输注白蛋白可降低AKI患者ICU病死率。
{"title":"[Association between albumin treatment and the prognosis of acute kidney injury patients: a retrospective study based on the MIMIC-IV database].","authors":"Xinyuan Zhang, Yan Zhuang, Linfeng Dai, Haidong Zhang, Qiuhua Chen, Qingfang Nie","doi":"10.3760/cma.j.cn121430-20230901-00723","DOIUrl":"https://doi.org/10.3760/cma.j.cn121430-20230901-00723","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To assess the impact of albumin (Alb) administration on the prognosis of patients with acute kidney injury (AKI).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Clinical data of AKI patients in the intensive care unit (ICU) were retrospectively analyzed from the American Medical Information Mart of Intensive Care-IV (MIMIC-IV), including demographic data, acute physiology score (APS), comorbidities, vital signs, laboratory indicators, treatment status, ICU length of stay, and outcome indicators. The main outcome measure is ICU mortality. AKI patients were divided into Alb infusion group and Alb non infusion group based on whether they received Alb treatment. Multiple imputation was used to process missing data and eliminate variables that missing more than 30%. To ensure the stability of the results, propensity score matching (PSM) and inverse probability weighting (IPW) were used to correct the results. Using Kaplan-Meier survival curve and Cox proportional hazards regression model to evaluate the effect of Alb infusion on ICU survival rate in AKI patients. Perform subgroup analysis based on patient age, gender, and comorbidities to evaluate the prognostic effects of Alb on different patient subgroups.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 6 390 AKI patients were included, including 1 721 in the Alb infusion group and 4 669 in the Alb non infusion group. After adjusting for key covariates in the Cox regression model, compared with the Alb non infusion group, patients in the Alb infusion group were significantly younger in age, with APS III score, proportion of vasoactive drugs and continuous renal replacement therapy (CRRT) use, sepsis proportion, heart rate, respiratory frequency, aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatinine (Cr), lactic acid (Lac), and arterial partial pressure of carbon dioxide (PaCO&lt;sub&gt;2&lt;/sub&gt;) levels significantly higher. The proportion of hypertension, myocardial infarction, and congestive heart failure, as well as blood pressure, urine output, platelet count (PLT), and Alb levels were significantly lower. The results of univariate and multivariate Cox regression analysis on the raw data showed that the risk of death in the Alb infusion group was significantly lower than that in the Alb non infusion group [hazard ratio (HR) = 0.69, 95% confidence interval (95%CI) was 0.60-0.80, all P &lt; 0.05]. The results after propensity score matching (PSM) and inverse probability weighting (IPW) processing are consistent with the original data trend (both P &lt; 0.05). The Kaplan-Meier survival curve showed that the cumulative survival rate during ICU stay in the Alb infusion group was significantly higher than that in the Alb non infusion group (24.48% vs. 12.17%, Log-Rank test: χ&lt;sup&gt;2&lt;/sup&gt; = 74.26, P &lt; 0.05). Subgroup analysis shows that Alb infusion has a more significant survival benefit for AKI patients who use vasoactive drugs, have concurrent sepsis, and do not have liver diseas","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 3","pages":"280-286"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143812524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis of clinical characteristics and related risk factors of patients with Clostridioides difficile infection in the intensive care unit]. 重症监护病房艰难梭菌感染患者临床特点及相关危险因素分析
Q3 Medicine Pub Date : 2025-03-01 DOI: 10.3760/cma.j.cn121430-20240725-00633
Hongming Yu, Qinfu Liu, Shenglin Su, Gang Li, Xiaojun Yang

Objective: To investigate the clinical characteristics and related risk factors of Clostridium difficile infection (CDI) in intensive care unit (ICU).

Methods: A retrospective study was conducted. Patients with diarrhea admitted to the ICU of the General Hospital of Ningxia Medical University from May 1 to August 30, 2023 were selected. Patients were divided into CDI group and non-CDI group based on the presence or absence of CDI. Clinical data from two groups of patients meeting the criteria were collected and compared, including gender, age, acute physiology and chronic health evaluation II (APACHE II), length of hospital stay, serum lactic acid, parenteral nutrition time, white blood cell count (WBC), procalcitonin (PCT), C-reactive protein (CRP), coagulation indicators, albumin, antibiotic exposure, etc. Multivariate Logistic regression analysis was performed to analyze the risk factors for CDI in ICU diarrhea patients. Receiver operator characteristic curve (ROC curve) was drawn to analyze the predictive value of each index for CDI in diarrhea patients.

Results: A total of 24 patients with diarrhea were enrolled, including 9 patients in the CDI group and 15 patients in the non-CDI group. The time of parenteral nutrition in the CDI group was significantly longer than that in the non-CDI group [days: 18.0 (13.5, 19.5) vs. 10.0 (4.0, 18.0)], the serum lactic acid level [mmol/L: 4.40 (3.00, 15.25) vs. 2.50 (1.90, 3.20)] and the ratio of serum lactic acid > 3.9 mmol/L [66.67% (6/9) vs. 6.67% (1/15)] were significantly higher than those in the non-CDI group, with statistical significance (all P < 0.05). Multivariate binary Logistic regression analysis showed that the serum lactic acid level of the patients was an independent risk factor for CDI [odds ratio (OR) = 3.193, 95% confidence interval (95%CI) was 1.011-10.080, P = 0.048]. ROC curve showed that serum lactic acid level had a high predictive value for CDI in ICU patients with diarrhea, and the area under the curve (AUC) was 0.815, respectively. When the cut-off value of serum lactic acid was 3.9 mmol/L, the sensitivity was 66.7% and the specificity was 93.3%.

Conclusion: Patients with diarrhea who have higher serum lactate levels (> 3.9 mmol/L) on admission are at increased risk of developing CDI.

目的:探讨重症监护病房(ICU)难辨梭菌(Clostridium difficile, CDI)感染的临床特点及相关危险因素。方法:回顾性研究。选择2023年5月1日至8月30日宁夏医科大学总医院ICU收治的腹泻患者。根据有无CDI分为CDI组和非CDI组。收集两组符合标准的患者的临床资料,包括性别、年龄、急性生理和慢性健康评估II (APACHE II)、住院时间、血清乳酸、肠外营养时间、白细胞计数(WBC)、降钙素原(PCT)、c反应蛋白(CRP)、凝血指标、白蛋白、抗生素暴露等。采用多因素Logistic回归分析ICU腹泻患者发生CDI的危险因素。绘制受试者操作特征曲线(Receiver operator characteristic curve, ROC),分析各指标对腹泻患者CDI的预测价值。结果:共纳入24例腹泻患者,其中CDI组9例,非CDI组15例。CDI组患儿肠外营养时间明显长于非CDI组[天数:18.0 (13.5,19.5)vs. 10.0(4.0, 18.0)],血清乳酸水平[mmol/L: 4.40 (3.00, 15.25) vs. 2.50(1.90, 3.20)]和血清乳酸浓度比值[66.67% (6/9)vs. 6.67%(1/15)]均显著高于非CDI组,差异均有统计学意义(均P < 0.05)。多因素二元Logistic回归分析显示,患者血清乳酸水平是CDI的独立危险因素[优势比(OR) = 3.193, 95%可信区间(95% ci)为1.011 ~ 10.080,P = 0.048]。ROC曲线显示,血清乳酸水平对ICU腹泻患者CDI有较高的预测价值,曲线下面积(AUC)分别为0.815。当血清乳酸临界值为3.9 mmol/L时,敏感性为66.7%,特异性为93.3%。结论:入院时血清乳酸水平(> 3.9 mmol/L)较高的腹泻患者发生CDI的风险增加。
{"title":"[Analysis of clinical characteristics and related risk factors of patients with Clostridioides difficile infection in the intensive care unit].","authors":"Hongming Yu, Qinfu Liu, Shenglin Su, Gang Li, Xiaojun Yang","doi":"10.3760/cma.j.cn121430-20240725-00633","DOIUrl":"https://doi.org/10.3760/cma.j.cn121430-20240725-00633","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the clinical characteristics and related risk factors of Clostridium difficile infection (CDI) in intensive care unit (ICU).</p><p><strong>Methods: </strong>A retrospective study was conducted. Patients with diarrhea admitted to the ICU of the General Hospital of Ningxia Medical University from May 1 to August 30, 2023 were selected. Patients were divided into CDI group and non-CDI group based on the presence or absence of CDI. Clinical data from two groups of patients meeting the criteria were collected and compared, including gender, age, acute physiology and chronic health evaluation II (APACHE II), length of hospital stay, serum lactic acid, parenteral nutrition time, white blood cell count (WBC), procalcitonin (PCT), C-reactive protein (CRP), coagulation indicators, albumin, antibiotic exposure, etc. Multivariate Logistic regression analysis was performed to analyze the risk factors for CDI in ICU diarrhea patients. Receiver operator characteristic curve (ROC curve) was drawn to analyze the predictive value of each index for CDI in diarrhea patients.</p><p><strong>Results: </strong>A total of 24 patients with diarrhea were enrolled, including 9 patients in the CDI group and 15 patients in the non-CDI group. The time of parenteral nutrition in the CDI group was significantly longer than that in the non-CDI group [days: 18.0 (13.5, 19.5) vs. 10.0 (4.0, 18.0)], the serum lactic acid level [mmol/L: 4.40 (3.00, 15.25) vs. 2.50 (1.90, 3.20)] and the ratio of serum lactic acid > 3.9 mmol/L [66.67% (6/9) vs. 6.67% (1/15)] were significantly higher than those in the non-CDI group, with statistical significance (all P < 0.05). Multivariate binary Logistic regression analysis showed that the serum lactic acid level of the patients was an independent risk factor for CDI [odds ratio (OR) = 3.193, 95% confidence interval (95%CI) was 1.011-10.080, P = 0.048]. ROC curve showed that serum lactic acid level had a high predictive value for CDI in ICU patients with diarrhea, and the area under the curve (AUC) was 0.815, respectively. When the cut-off value of serum lactic acid was 3.9 mmol/L, the sensitivity was 66.7% and the specificity was 93.3%.</p><p><strong>Conclusion: </strong>Patients with diarrhea who have higher serum lactate levels (> 3.9 mmol/L) on admission are at increased risk of developing CDI.</p>","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 3","pages":"251-254"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143812481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Current status and visual analysis of the burn-related sepsis]. [烧伤相关脓毒症的现状及目视分析]。
Q3 Medicine Pub Date : 2025-03-01 DOI: 10.3760/cma.j.cn121430-20240806-00669
Like Zhang, Wei Yi, Lijing Zhu, Weibo Xie, Zhicheng Gu, Guosheng Wu, Zhaofan Xia
<p><strong>Objective: </strong>To explore the current status, evolution, hot topics, and future research trends in the field of burn-related sepsis research through a visual analysis of literature.</p><p><strong>Methods: </strong>A bibliometric method was employed to retrieve articles related to burn-related sepsis from January 1, 1994, to May 16, 2024, in the China National Knowledge Infrastructure (CNKI) and the Web of Science database. The CiteSpace 6.3.R1 software was used to analyze the retrieved literature. The number of publications, authors, countries, and institutions in both Chinese and English literature was statistically analyzed. Co-occurrence analysis, clustering analysis, and co-citation analysis of keywords were performed.</p><p><strong>Results: </strong>A total of 1 090 articles from the CNKI database and 1 143 articles from the Web of Science database were retrieved. Over the past 20 years, the volume of Chinese publications has remained stable, although there has been a slight decline in the past two years. In contrast, the number of English publications, after a period of growth, showed a sharp decline over the past three years. In Chinese literature, 1 457 authors published articles on burn-related sepsis as first authors, with 14 core authors publishing four or more articles. In English literature, 98 authors published articles on burn-related sepsis as first authors. Research on burn-related sepsis was conducted by 76 countries, with the United States having the most collaborations and publications. Globally, 1 349 institutions published articles on burn-related sepsis, with the top institutions being the First Affiliated Hospital of the PLA General Hospital (8 articles) for Chinese literature and the University of Texas Medical Branch (57 articles) for English literature. In the co-occurrence analysis, 208 Chinese keywords and 211 English keywords were included. Excluding keywords related to search terms, the top five most frequent keywords in Chinese literature were burn, sepsis, infection, severe burn, and procalcitonin; the top five most frequent keywords in English literature were sepsis, septic shock, mortality, injury, and burn injury. Chinese keyword analysis identified six clusters, with the largest being sepsis, followed by procalcitonin, infection, and severe burn. English keyword analysis identified seven clusters, with the largest being expression, followed by epidemiology, inhalation injury, and acute kidney injury. The persistent clusters in Chinese literature were procalcitonin, with recent emerging nodes being severe burn, inflammatory response, platelets, and predictive value. In English literature, the persistent clusters were inhalation injury and nitric oxide, with recent emerging nodes being continuous renal replacement therapy, hemorrhagic shock, and early enteral nutrition. The longest-lasting emergent keyword in Chinese literature was delayed resuscitation (2003-2010), with the highest emergent stre
目的:通过对文献的直观分析,探讨烧伤相关脓毒症研究的现状、演变、热点问题及未来研究趋势。方法:采用文献计量学方法检索中国知网(CNKI)和Web of Science数据库中1994年1月1日至2024年5月16日期间与烧伤相关脓毒症相关的文献。CiteSpace 6.3。使用R1软件对检索到的文献进行分析。统计分析了中英文文献的出版物、作者、国家和机构的数量。对关键词进行共现分析、聚类分析和共被引分析。结果:共检索到CNKI数据库中的1 090篇文章和Web of Science数据库中的1 143篇文章。在过去的20年里,中文出版物的数量一直保持稳定,尽管在过去的两年里有轻微的下降。相比之下,英文出版物的数量在经过一段时间的增长后,在过去三年中急剧下降。在中国文献中,有1457位作者以第一作者发表了烧伤相关脓毒症的文章,其中14位核心作者发表了4篇及以上的文章。在英国文献中,有98位作者以第一作者身份发表了与烧伤相关的脓毒症的文章。76个国家对烧伤相关败血症进行了研究,其中美国的合作和发表最多。在全球范围内,共有1349家机构发表了与烧伤相关的脓毒症相关的论文,其中中文文献最多的是解放军总医院第一附属医院(8篇),英文文献最多的是德克萨斯大学医学院(57篇)。共现分析共包括208个中文关键词和211个英文关键词。排除与搜索词相关的关键词,中文文献中出现频率最高的前5个关键词是烧伤、败血症、感染、重度烧伤和降钙素原;英文文献中出现频率最高的前5个关键词是败血症、脓毒性休克、死亡率、损伤和烧伤。中文关键词分析确定了6个集群,最大的集群是脓毒症,其次是降钙素原、感染和严重烧伤。英文关键词分析共鉴定出7个聚类,最大的聚类是表达,其次是流行病学、吸入性损伤和急性肾损伤。在中国文献中,持续的群集是降钙素原,最近出现的淋巴结是严重烧伤、炎症反应、血小板和预测价值。在英国文献中,持续的集群是吸入性损伤和一氧化氮,最近出现的节点是持续肾替代治疗、失血性休克和早期肠内营养。中国文献中持续时间最长的紧急关键词是延迟复苏(2003-2010),紧急强度最高的是严重烧伤。在英语文献中,持续时间最长的紧急关键词是一氧化氮(2007-2012)、管理(2019-2024)和冲击(2019-2024),每个关键词持续时间为5年,其中热损伤的紧急强度最高。结论:烧伤相关脓毒症的研究已经从关注发病机制和死亡率的早期研究转向关注预防、治疗和早期诊断。未来的研究将重点放在烧伤相关脓毒症的早期诊断和危险因素上。
{"title":"[Current status and visual analysis of the burn-related sepsis].","authors":"Like Zhang, Wei Yi, Lijing Zhu, Weibo Xie, Zhicheng Gu, Guosheng Wu, Zhaofan Xia","doi":"10.3760/cma.j.cn121430-20240806-00669","DOIUrl":"https://doi.org/10.3760/cma.j.cn121430-20240806-00669","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To explore the current status, evolution, hot topics, and future research trends in the field of burn-related sepsis research through a visual analysis of literature.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A bibliometric method was employed to retrieve articles related to burn-related sepsis from January 1, 1994, to May 16, 2024, in the China National Knowledge Infrastructure (CNKI) and the Web of Science database. The CiteSpace 6.3.R1 software was used to analyze the retrieved literature. The number of publications, authors, countries, and institutions in both Chinese and English literature was statistically analyzed. Co-occurrence analysis, clustering analysis, and co-citation analysis of keywords were performed.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 1 090 articles from the CNKI database and 1 143 articles from the Web of Science database were retrieved. Over the past 20 years, the volume of Chinese publications has remained stable, although there has been a slight decline in the past two years. In contrast, the number of English publications, after a period of growth, showed a sharp decline over the past three years. In Chinese literature, 1 457 authors published articles on burn-related sepsis as first authors, with 14 core authors publishing four or more articles. In English literature, 98 authors published articles on burn-related sepsis as first authors. Research on burn-related sepsis was conducted by 76 countries, with the United States having the most collaborations and publications. Globally, 1 349 institutions published articles on burn-related sepsis, with the top institutions being the First Affiliated Hospital of the PLA General Hospital (8 articles) for Chinese literature and the University of Texas Medical Branch (57 articles) for English literature. In the co-occurrence analysis, 208 Chinese keywords and 211 English keywords were included. Excluding keywords related to search terms, the top five most frequent keywords in Chinese literature were burn, sepsis, infection, severe burn, and procalcitonin; the top five most frequent keywords in English literature were sepsis, septic shock, mortality, injury, and burn injury. Chinese keyword analysis identified six clusters, with the largest being sepsis, followed by procalcitonin, infection, and severe burn. English keyword analysis identified seven clusters, with the largest being expression, followed by epidemiology, inhalation injury, and acute kidney injury. The persistent clusters in Chinese literature were procalcitonin, with recent emerging nodes being severe burn, inflammatory response, platelets, and predictive value. In English literature, the persistent clusters were inhalation injury and nitric oxide, with recent emerging nodes being continuous renal replacement therapy, hemorrhagic shock, and early enteral nutrition. The longest-lasting emergent keyword in Chinese literature was delayed resuscitation (2003-2010), with the highest emergent stre","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 3","pages":"255-261"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143812532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Design of a head auxiliary support device in prone position]. 一种俯卧位头部辅助支撑装置的设计
Q3 Medicine Pub Date : 2025-03-01 DOI: 10.3760/cma.j.cn121430-20240723-00625
Xinyu Li, Weilian Ni, Weiqiang Huo, Xueqin Zhao

Prone position ventilation (PPV) is an important protective strategy for lung ventilation, widely used in clinical practice, especially since the novel coronavirus infection pandemic. Since PPV is a non-physiological position, improper implementation and management can lead to serious adverse events such as pressure injury, facial edema, unplanned extubation and (or) reintubation, and even asphyxia. At present, preventive and protective strategies are mainly used to manage PPV-related complications in clinical practice. These strategies not only increase the workload of medical staff and the use of consumables, but also increase the medical cost of patients, further burdening patients and their families economically. To overcome the above problems, the medical staff of the department of critical care medicine of Tianjin Third Central Hospital designed a prone position head auxiliary support device and obtained a national utility model patent (patent number: ZL 2022 2 1751906.3). The device consists of annular plate, folding plate, support frame, reflector and wheel bodies. It serves to reduce pressure on the head and facial skin, while also exposing the mouth, nose, eyes, and ears to the hollow position of the annular plate according to the patient's position. At the same time, the patient's face or side skin can be observed through the lower reflector. The height of the annular plate was adjusted by adjusting the support frame, and the head was raised to reduce facial edema. The setting of strip groove, through hole and hook can sort out the facial pipeline, keep the drainage unobstructed, prevent catheter displacement and unplanned extubation, and has certain clinical promotion and practical value.

俯卧位通气(PPV)是一种重要的肺通气保护策略,尤其在新型冠状病毒感染大流行以来被广泛应用于临床。由于PPV是一个非生理体位,实施和管理不当会导致严重的不良事件,如压力损伤、面部水肿、计划外拔管和(或)再插管,甚至窒息。目前,临床主要采用预防和保护策略来管理ppv相关并发症。这些策略不仅增加了医务人员的工作量和耗材的使用,而且增加了患者的医疗费用,进一步加重了患者及其家庭的经济负担。针对上述问题,天津市第三中心医院重症医学部医护人员设计了一种俯卧位头部辅助支撑装置,并获得了国家实用新型专利(专利号:ZL 2022 2 1751906.3)。该装置由环形板、折叠板、支撑架、反射板和轮体组成。它的作用是减轻对头部和面部皮肤的压力,同时根据患者的体位,将口、鼻、眼、耳暴露在环形板的中空位置。同时,可通过下反射镜观察患者的面部或侧皮肤。通过调节支撑架调节环形板高度,抬高头部,减少面部水肿。条形槽、通孔、钩的设置可以梳理面部管路,保持引流通畅,防止导管移位和计划外拔管,具有一定的临床推广和实用价值。
{"title":"[Design of a head auxiliary support device in prone position].","authors":"Xinyu Li, Weilian Ni, Weiqiang Huo, Xueqin Zhao","doi":"10.3760/cma.j.cn121430-20240723-00625","DOIUrl":"https://doi.org/10.3760/cma.j.cn121430-20240723-00625","url":null,"abstract":"<p><p>Prone position ventilation (PPV) is an important protective strategy for lung ventilation, widely used in clinical practice, especially since the novel coronavirus infection pandemic. Since PPV is a non-physiological position, improper implementation and management can lead to serious adverse events such as pressure injury, facial edema, unplanned extubation and (or) reintubation, and even asphyxia. At present, preventive and protective strategies are mainly used to manage PPV-related complications in clinical practice. These strategies not only increase the workload of medical staff and the use of consumables, but also increase the medical cost of patients, further burdening patients and their families economically. To overcome the above problems, the medical staff of the department of critical care medicine of Tianjin Third Central Hospital designed a prone position head auxiliary support device and obtained a national utility model patent (patent number: ZL 2022 2 1751906.3). The device consists of annular plate, folding plate, support frame, reflector and wheel bodies. It serves to reduce pressure on the head and facial skin, while also exposing the mouth, nose, eyes, and ears to the hollow position of the annular plate according to the patient's position. At the same time, the patient's face or side skin can be observed through the lower reflector. The height of the annular plate was adjusted by adjusting the support frame, and the head was raised to reduce facial edema. The setting of strip groove, through hole and hook can sort out the facial pipeline, keep the drainage unobstructed, prevent catheter displacement and unplanned extubation, and has certain clinical promotion and practical value.</p>","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 3","pages":"297-299"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143812552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Impact and clinical significance of different types of fluid resuscitation on the glycocalyx in patients with early sepsis and septic shock: a single center, prospective, randomized controlled trial]. [不同类型液体复苏对早期脓毒症及脓毒性休克患者糖萼的影响及临床意义:单中心、前瞻性、随机对照试验]。
Q3 Medicine Pub Date : 2025-03-01 DOI: 10.3760/cma.j.cn121430-20240711-00583
Lipeng Dong, Xinhui Wu, Congcong Zhao, Shengmei Ge, Zhihong Liu
<p><strong>Objective: </strong>To evaluate the risks and benefits of different resuscitation fluids in patients with early sepsis and septic shock by observing and comparing clinical indicators, clinical outcomes, and the concentration changes of glycocalyx biomarkers, and to determine how to appropriately select suitable resuscitation fluids for sepsis patients to aid fluid therapy.</p><p><strong>Methods: </strong>A single center, prospective, randomized controlled trial was conducted. Patients with early sepsis and septic shock who have required fluid resuscitation after capacity status assessment admitted to the department of critical care medicine of Fourth Hospital of Hebei Medical University from April to October 2023 were enrolled. Patients were randomly assigned to either the experimental group (balanced crystalloid solution+albumin) or the control group (balanced crystalloid solution) by a random number table method. Clinical data of both groups of patients before and after resuscitation at 3, 8, and 24 hours were monitored, and blood samples were collected, enzyme-linked immunosorbent assay (ELISA) was used to measure the concentration of plasma glycocalyx biomarker syndecan-1. The 28-day and 90-day survival rates and complications were also assessed.</p><p><strong>Results: </strong>A total of 66 patients were enrolled, including 44 in the experimental group and 22 in the control group. The baseline data of two groups were balanced and comparable. There was no statistically significant difference in the plasma concentration of syndecan-1 between the experimental group and the control group before and after resuscitation, and both showed a trend of first increasing and then decreasing. However, the plasma syndecan-1 level in the control group at 8 hours and 24 hours after resuscitation were significantly higher than the baseline level before resuscitation [ng/L: 19.02 (14.41, 27.80), 18.95 (12.40, 22.50) vs. 14.67 (11.57, 21.14), both P < 0.05], while there was no statistically significant difference at any time point within the experimental group. The correlation analysis between plasma syndecan-1 level and lactic acid, albumin, and sequential organ failure assessment (SOFA) in all patients showed that a positive correlation between syndecan-1 level and SOFA score before resuscitation (r = 0.247, P = 0.046), and a negative correlation between syndecan-1 level and albumin level at 24 hours after resuscitation (r = -0.308, P = 0.012). There were no statistically significant differences in 28-day and 90-day mortality, length of hospital stay, length of intensive care unit (ICU) stay, duration of mechanical ventilation, blood purification time, number of organ injuries, and complications between the two groups. However, the baseline albumin level in the experimental group was significantly lower than that in the control group (g/L: 28.7±4.5 vs. 31.6±4.2, P < 0.05). Analysis of clinical treatment data showed that compared with the control gr
目的通过观察和比较早期脓毒症和脓毒性休克患者的临床指标、临床结局以及糖萼生物标志物的浓度变化,评估不同复苏液对患者的风险和益处,并确定如何为脓毒症患者合理选择合适的复苏液,以辅助液体疗法:方法:进行了一项单中心、前瞻性、随机对照试验。方法:采用单中心前瞻性随机对照试验的方法,选取 2023 年 4 月至 10 月期间河北医科大学第四医院重症医学科收治的早期脓毒症和脓毒性休克患者为研究对象。通过随机数字表法将患者随机分配到实验组(平衡晶体液+白蛋白)或对照组(平衡晶体液)。监测两组患者复苏前后 3、8 和 24 小时的临床数据,并采集血液样本,采用酶联免疫吸附试验(ELISA)测定血浆糖萼生物标志物辛迪卡-1 的浓度。此外,还评估了28天和90天的存活率及并发症:共有 66 例患者入组,其中实验组 44 例,对照组 22 例。两组的基线数据均衡且具有可比性。实验组与对照组在复苏前后的血浆辛迪加-1浓度差异无统计学意义,均呈先升高后降低的趋势。然而,对照组在复苏后 8 小时和 24 小时的血浆辛迪加-1 水平明显高于复苏前的基线水平[ng/L:19.02(14.41,27.80),18.95(12.40,22.50) vs. 14.67(11.57,21.14),均 P <0.05],而实验组在任何时间点的差异均无统计学意义。所有患者血浆辛迪卡-1水平与乳酸、白蛋白和序贯器官衰竭评估(SOFA)之间的相关性分析表明,复苏前辛迪卡-1水平与SOFA评分呈正相关(r = 0.247,P = 0.046),复苏后24小时辛迪卡-1水平与白蛋白水平呈负相关(r = -0.308,P = 0.012)。两组患者在 28 天和 90 天的死亡率、住院时间、重症监护室(ICU)住院时间、机械通气时间、血液净化时间、器官损伤数量和并发症方面没有明显的统计学差异。但实验组的白蛋白基线水平明显低于对照组(g/L:28.7±4.5 vs. 31.6±4.2,P <0.05)。临床治疗数据分析显示,与对照组相比,实验组在复苏后 8 小时和 24 小时的绝对乳酸水平较低[mmol/L:8 小时为 1.30(1.00,1.88) vs. 1.60 (1.30, 3.05),24 小时为 1.15 (0.80, 1.78) vs. 1.55 (1.08, 2.05),均 P <0.05],乳酸清除率更高[8 小时为 45% (27%, 56%) vs. 20% (-4%, 46%), 24 小时为 55% (34%, 70%) vs. 34% (-14%, 59%),均 P <0.05]。不过,在复苏过程中,两组患者的液体复苏量、血管活性药物使用量和氧合指数差异无统计学意义。多变量逻辑回归分析显示,体重指数(BMI)与 90 天死亡率独立相关[比值比(OR)= 1.991,95% 置信区间(95%CI)为 1.023-3.387,P = 0.043]:对早期脓毒症和脓毒性休克患者进行液体复苏时,使用平衡晶体液和平衡晶体液联合白蛋白复苏,血浆辛迪加-1水平无明显差异,对患者28天和90天预后、住院时间、并发症等方面的影响也无统计学差异。不过,与平衡晶体液相比,平衡晶体液与白蛋白联合用于脓毒症患者的液体复苏具有更低的乳酸水平和更好的乳酸清除效果,但仍需通过大规模随机对照试验进一步验证。
{"title":"[Impact and clinical significance of different types of fluid resuscitation on the glycocalyx in patients with early sepsis and septic shock: a single center, prospective, randomized controlled trial].","authors":"Lipeng Dong, Xinhui Wu, Congcong Zhao, Shengmei Ge, Zhihong Liu","doi":"10.3760/cma.j.cn121430-20240711-00583","DOIUrl":"https://doi.org/10.3760/cma.j.cn121430-20240711-00583","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To evaluate the risks and benefits of different resuscitation fluids in patients with early sepsis and septic shock by observing and comparing clinical indicators, clinical outcomes, and the concentration changes of glycocalyx biomarkers, and to determine how to appropriately select suitable resuscitation fluids for sepsis patients to aid fluid therapy.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A single center, prospective, randomized controlled trial was conducted. Patients with early sepsis and septic shock who have required fluid resuscitation after capacity status assessment admitted to the department of critical care medicine of Fourth Hospital of Hebei Medical University from April to October 2023 were enrolled. Patients were randomly assigned to either the experimental group (balanced crystalloid solution+albumin) or the control group (balanced crystalloid solution) by a random number table method. Clinical data of both groups of patients before and after resuscitation at 3, 8, and 24 hours were monitored, and blood samples were collected, enzyme-linked immunosorbent assay (ELISA) was used to measure the concentration of plasma glycocalyx biomarker syndecan-1. The 28-day and 90-day survival rates and complications were also assessed.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 66 patients were enrolled, including 44 in the experimental group and 22 in the control group. The baseline data of two groups were balanced and comparable. There was no statistically significant difference in the plasma concentration of syndecan-1 between the experimental group and the control group before and after resuscitation, and both showed a trend of first increasing and then decreasing. However, the plasma syndecan-1 level in the control group at 8 hours and 24 hours after resuscitation were significantly higher than the baseline level before resuscitation [ng/L: 19.02 (14.41, 27.80), 18.95 (12.40, 22.50) vs. 14.67 (11.57, 21.14), both P &lt; 0.05], while there was no statistically significant difference at any time point within the experimental group. The correlation analysis between plasma syndecan-1 level and lactic acid, albumin, and sequential organ failure assessment (SOFA) in all patients showed that a positive correlation between syndecan-1 level and SOFA score before resuscitation (r = 0.247, P = 0.046), and a negative correlation between syndecan-1 level and albumin level at 24 hours after resuscitation (r = -0.308, P = 0.012). There were no statistically significant differences in 28-day and 90-day mortality, length of hospital stay, length of intensive care unit (ICU) stay, duration of mechanical ventilation, blood purification time, number of organ injuries, and complications between the two groups. However, the baseline albumin level in the experimental group was significantly lower than that in the control group (g/L: 28.7±4.5 vs. 31.6±4.2, P &lt; 0.05). Analysis of clinical treatment data showed that compared with the control gr","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 3","pages":"237-244"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143812564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical features and early warning of the sepsis in immunocompromised host sepsis]. 【免疫功能低下宿主败血症的临床特点及早期预警】。
Q3 Medicine Pub Date : 2025-03-01 DOI: 10.3760/cma.j.cn121430-20240729-00638
Yanqing Chen, Runjing Guo, Xiao Huang, Xiaoli Liu, Huanhuan Tian, Bingjie Lyu, Fangyu Ning, Tao Wang, Dong Hao
<p><strong>Objective: </strong>To explore the clinical features of the sepsis in immunocompromised hosts and establish an early warning equation.</p><p><strong>Methods: </strong>A retrospective study was conducted on sepsis patients admitted to the intensive care unit (ICU) of Binzhou Medical University Hospital from October 2011 to October 2022. General information, infection site, etiology results and drug susceptibility, clinical symptoms, inflammatory indicators, acute physiology and chronic health status evaluation II (APACHE II), sequential organ failure assessment (SOFA), incidence of immune paralysis, and outcome during hospitalization were collected. Based on whether they met the diagnostic criteria for immunocompromised hosts, patients were divided into immunocompromised group and immune normal group. The clinical information of the two groups were compared. Multivariate Logistic regression was used to analyze the risk factors of patients with immunocompromised sepsis and the regression equation model was initially established. Omnibus test and Hosmer-Lemeshow test were used to evaluate the model.</p><p><strong>Results: </strong>A total of 169 patients with sepsis were included, including 61 in the immunocompromised group and 108 in the normal immune group. The top 3 infection sites in the immunocompromised group were bloodstream infection, pulmonary infection and abdominal infection. The top 3 infection sites in the normal immune group were pulmonary infection, bloodstream infection and abdominal infection. The infection rate of Gram-negative bacteria in the immunocompromised group was significantly lower than that in the normal group [49.2% (30/61) vs. 64.8% (70/108), P < 0.05]. The infection rate of Gram-positive bacteria [27.9% (17/61) vs. 13.9% (15/108)] and multidrug-resistant bacteria [54.1% (33/61) vs. 29.6% (32/108)] were significantly higher than those in normal immune group (both P < 0.05). In terms of clinical symptoms, the proportion of fever in the immunocompromised group was significantly lower than that in the immune normal group [49.2% (30/61) vs. 66.7% (72/108), P < 0.05]. Neutrophil count (NEU) and neutrophil percentage (NEU%) in the immunocompromised group were significantly lower than those in the normal immune group. Lymphocyte percentage (LYM%), neutrophil/lymphocyte ratio (NLR), C-reactive protein (CRP), procalcitonin (PCT), APACHE II score, combined shock rate, incidence of immune paralysis, and mortality during hospitalization in the immunocompromised group were significantly higher than those in the normal immune group. Logistic regression analysis showed that NLR, CRP and PCT were risk factors for patients with immunocompromised sepsis (all P < 0.05). The above indicators were used as covariables to construct a Logistic regression equation, that was, Logit (P) = 0.025X<sub>1</sub>+0.010X<sub>2</sub>+0.013X<sub>3</sub>-2.945, where X<sub>1</sub>, X<sub>2</sub> and X<sub>3</sub> represent NLR, CRP and PCT respe
目的:探讨免疫功能低下宿主脓毒症的临床特点,建立脓毒症早期预警方程。方法:对2011年10月至2022年10月滨州医科大学附属医院重症监护病房(ICU)收治的脓毒症患者进行回顾性研究。收集患者的一般情况、感染部位、病因结果及药敏、临床症状、炎症指标、急性生理和慢性健康状况评估II (APACHE II)、序事性器官衰竭评估(SOFA)、免疫瘫痪发生率及住院期间转诊情况。根据是否符合免疫功能低下宿主的诊断标准,将患者分为免疫功能低下组和免疫正常组。比较两组患者的临床资料。采用多因素Logistic回归分析免疫功能低下脓毒症患者的危险因素,初步建立回归方程模型。采用Omnibus检验和Hosmer-Lemeshow检验对模型进行评价。结果:共纳入169例脓毒症患者,其中免疫功能低下组61例,免疫正常组108例。免疫功能低下组感染部位前3位依次为血流感染、肺部感染和腹部感染。免疫正常组感染部位前3位依次为肺部感染、血流感染和腹部感染。免疫功能低下组革兰氏阴性菌感染率显著低于正常组[49.2%(30/61)比64.8% (70/108),P < 0.05]。革兰氏阳性菌感染率[27.9%(17/61)比13.9%(15/108)]和耐多药菌感染率[54.1%(33/61)比29.6%(32/108)]均显著高于正常免疫组(P < 0.05)。在临床症状方面,免疫功能低下组发热比例明显低于免疫正常组[49.2%(30/61)比66.7% (72/108),P < 0.05]。免疫功能低下组中性粒细胞计数(NEU)和中性粒细胞百分比(NEU%)显著低于正常免疫组。免疫功能低下组淋巴细胞百分率(LYM%)、中性粒细胞/淋巴细胞比值(NLR)、c反应蛋白(CRP)、降钙素原(PCT)、APACHEⅱ评分、合并休克率、免疫麻痹发生率、住院期间死亡率均显著高于免疫正常组。Logistic回归分析显示NLR、CRP和PCT是免疫功能低下脓毒症患者的危险因素(均P < 0.05)。将上述指标作为协变量,构建Logistic回归方程,即Logit (P) = 0.025X1+0.010X2+0.013X3-2.945,其中X1、X2、X3分别代表NLR、CRP和PCT。综合检验和Hosmer-Lemeshow检验表明,该模型拟合良好,具有一定的预警价值。结论:免疫功能低下脓毒症患者炎症反应更强烈,以革兰氏阴性菌为主,革兰氏阳性菌感染和多重耐药感染发生率较高。脓毒症后的病情严重程度、住院死亡率、休克发生率和免疫麻痹发生率均显著增高。NLR、CRP和PCT是免疫功能低下患者脓毒症的独立危险因素。由此构建的回归方程对免疫功能低下脓毒症患者可能具有早期预警意义。
{"title":"[Clinical features and early warning of the sepsis in immunocompromised host sepsis].","authors":"Yanqing Chen, Runjing Guo, Xiao Huang, Xiaoli Liu, Huanhuan Tian, Bingjie Lyu, Fangyu Ning, Tao Wang, Dong Hao","doi":"10.3760/cma.j.cn121430-20240729-00638","DOIUrl":"https://doi.org/10.3760/cma.j.cn121430-20240729-00638","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To explore the clinical features of the sepsis in immunocompromised hosts and establish an early warning equation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A retrospective study was conducted on sepsis patients admitted to the intensive care unit (ICU) of Binzhou Medical University Hospital from October 2011 to October 2022. General information, infection site, etiology results and drug susceptibility, clinical symptoms, inflammatory indicators, acute physiology and chronic health status evaluation II (APACHE II), sequential organ failure assessment (SOFA), incidence of immune paralysis, and outcome during hospitalization were collected. Based on whether they met the diagnostic criteria for immunocompromised hosts, patients were divided into immunocompromised group and immune normal group. The clinical information of the two groups were compared. Multivariate Logistic regression was used to analyze the risk factors of patients with immunocompromised sepsis and the regression equation model was initially established. Omnibus test and Hosmer-Lemeshow test were used to evaluate the model.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 169 patients with sepsis were included, including 61 in the immunocompromised group and 108 in the normal immune group. The top 3 infection sites in the immunocompromised group were bloodstream infection, pulmonary infection and abdominal infection. The top 3 infection sites in the normal immune group were pulmonary infection, bloodstream infection and abdominal infection. The infection rate of Gram-negative bacteria in the immunocompromised group was significantly lower than that in the normal group [49.2% (30/61) vs. 64.8% (70/108), P &lt; 0.05]. The infection rate of Gram-positive bacteria [27.9% (17/61) vs. 13.9% (15/108)] and multidrug-resistant bacteria [54.1% (33/61) vs. 29.6% (32/108)] were significantly higher than those in normal immune group (both P &lt; 0.05). In terms of clinical symptoms, the proportion of fever in the immunocompromised group was significantly lower than that in the immune normal group [49.2% (30/61) vs. 66.7% (72/108), P &lt; 0.05]. Neutrophil count (NEU) and neutrophil percentage (NEU%) in the immunocompromised group were significantly lower than those in the normal immune group. Lymphocyte percentage (LYM%), neutrophil/lymphocyte ratio (NLR), C-reactive protein (CRP), procalcitonin (PCT), APACHE II score, combined shock rate, incidence of immune paralysis, and mortality during hospitalization in the immunocompromised group were significantly higher than those in the normal immune group. Logistic regression analysis showed that NLR, CRP and PCT were risk factors for patients with immunocompromised sepsis (all P &lt; 0.05). The above indicators were used as covariables to construct a Logistic regression equation, that was, Logit (P) = 0.025X&lt;sub&gt;1&lt;/sub&gt;+0.010X&lt;sub&gt;2&lt;/sub&gt;+0.013X&lt;sub&gt;3&lt;/sub&gt;-2.945, where X&lt;sub&gt;1&lt;/sub&gt;, X&lt;sub&gt;2&lt;/sub&gt; and X&lt;sub&gt;3&lt;/sub&gt; represent NLR, CRP and PCT respe","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 3","pages":"245-250"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143812526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research status of experimental animal models of sepsis]. 【脓毒症实验动物模型研究现状】。
Q3 Medicine Pub Date : 2025-03-01 DOI: 10.3760/cma.j.cn121430-20240226-00162
Zhenglin Chang, Bingsen Chen, Haojie Wu, Zhangkai Cheng, Baoqing Sun

Sepsis is a lethal condition resulting from the host's dysregulated response, involving complex pathophysiological mechanisms, including the host's biphasic immune response and metabolic disturbances. Diagnosing and treating sepsis remain formidable challenges, with the absence of definitive biomarkers and effective therapeutic interventions to date. Animal models of sepsis are pivotal in unraveling the disease's pathogenesis and identifying potential treatments, playing a crucial role in enhancing our comprehension of its intrinsic nature. However, there is no animal model that can comprehensively and accurately simulate the complex pathophysiological process of human sepsis. This review discusses the widely used sepsis animal models, exploring their advantages and limitations in terms of pathogenesis, inflammatory response, pathophysiological changes, and organ dysfunction. It summarizes the application scenarios and latest research advancements of these models and provides an outlook on potential future improvements.

脓毒症是宿主反应失调引起的致死性疾病,涉及宿主双相免疫反应和代谢紊乱等复杂的病理生理机制。迄今为止,由于缺乏明确的生物标志物和有效的治疗干预措施,诊断和治疗败血症仍然是一项艰巨的挑战。脓毒症的动物模型是揭示疾病发病机制和确定潜在治疗方法的关键,在增强我们对其内在本质的理解方面发挥着至关重要的作用。然而,目前还没有一种动物模型能够全面、准确地模拟人类脓毒症复杂的病理生理过程。本文综述了目前广泛应用的脓毒症动物模型,从其发病机制、炎症反应、病理生理变化和器官功能障碍等方面探讨了其优缺点。总结了这些模型的应用场景和最新研究进展,并对未来可能的改进进行了展望。
{"title":"[Research status of experimental animal models of sepsis].","authors":"Zhenglin Chang, Bingsen Chen, Haojie Wu, Zhangkai Cheng, Baoqing Sun","doi":"10.3760/cma.j.cn121430-20240226-00162","DOIUrl":"https://doi.org/10.3760/cma.j.cn121430-20240226-00162","url":null,"abstract":"<p><p>Sepsis is a lethal condition resulting from the host's dysregulated response, involving complex pathophysiological mechanisms, including the host's biphasic immune response and metabolic disturbances. Diagnosing and treating sepsis remain formidable challenges, with the absence of definitive biomarkers and effective therapeutic interventions to date. Animal models of sepsis are pivotal in unraveling the disease's pathogenesis and identifying potential treatments, playing a crucial role in enhancing our comprehension of its intrinsic nature. However, there is no animal model that can comprehensively and accurately simulate the complex pathophysiological process of human sepsis. This review discusses the widely used sepsis animal models, exploring their advantages and limitations in terms of pathogenesis, inflammatory response, pathophysiological changes, and organ dysfunction. It summarizes the application scenarios and latest research advancements of these models and provides an outlook on potential future improvements.</p>","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 3","pages":"310-316"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143812604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Zhonghua wei zhong bing ji jiu yi xue
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1